Standout Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2023 2026 2024145
  1. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2023)
    Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 60 standout
Sub-graph 1 of 21

Citing Papers

Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
2024 Standout
Crohn's disease
2024 Standout
5 intermediate papers

Works of Trevor Lissoos being referenced

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Trevor Lissoos 815 679 389 41 1.2k
Joep de Bruijne 732 594 443 46 1.5k
Marte Lie Høivik 990 1003 311 61 1.7k
Yago González‐Lama 781 959 195 47 1.4k
Manuel Mendizábal 582 264 476 62 1.1k
Hak Yang Kim 584 370 316 59 1.3k
E.V. Tsianos 637 277 442 52 1.2k
Jean Louis Dupas 967 1114 143 28 1.6k
Ming Lin 548 308 414 55 1.1k
Daniel R. Gaya 542 644 157 78 1.3k
Cyriel Ponsioen 575 665 163 39 1.2k

All Works

Loading papers...

Rankless by CCL
2026